Placebo 400 mg

DRUG3 trials

Sponsors

Stiefel, a GSK Company, Guangdong Zhongsheng Pharmaceutical Co., Ltd., Nanjing Nutrabuilding Bio-tech Co., Ltd.

Conditions

InfluenzaOnychomycosisPrediabetes

Phase 1

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

CompletedNCT03679143

Guangdong Zhongsheng Pharmaceutical Co., Ltd.Influenza

Start: 2018-09-20End: 2019-04-26Updated: 2019-08-14

Phase 2

Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

CompletedNCT00730405

Stiefel, a GSK CompanyOnychomycosis

Start: 2008-07-16End: 2010-02-19Updated: 2018-03-12

Unknown Phase

Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

RecruitingNCT07210684

Nanjing Nutrabuilding Bio-tech Co., Ltd.Prediabetes

Start: 2025-08-06End: 2026-03-15Target: 54Updated: 2025-10-07

Related Papers

Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects

Expert Opinion on Investigational Drugs2021-10-1717 citations